The DOI matches its Crossref record; 300 of the 300 references it cites were found in a registry or an index.
MMP‐9 in translation: from molecule to brain physiology, pathology, and therapy
Open accessAbstract
Matrix metalloproteinase‐9 (MMP‐9) is a member of the metzincin family of mostly extracellularly operating proteases. Despite the fact that all of these enzymes might be target promiscuous, with largely overlapping catalogs of potential substrates,MMP‐9 has recently emerged as a major and apparently unique player in brain physiology and pathology. The specificity of MMP‐9 may arise from its very local and time‐restricted actions, even when released in the brain from cells of various types, including neurons, glia, and leukocytes. In fact, the quantity of MMP‐9 is very low in the naive brain, but it is markedly activated at the levels of enzymatic activity, protein abundance, and gene expression following various physiological stimuli and pathological insults. Neuronal MMP‐9 participates in synaptic plasticity by controlling the shape of dendritic spines and function of excitatory synapses, thus playing a pivotal role in learning, memory, and cortical plasticity. When improperly unleashed,MMP‐9 contributes to a large variety of brain disorders, including epilepsy, schizophrenia, autism spectrum disorder, brain injury, stroke, neurodegeneration, pain, brain tumors, etc. The foremost mechanism of action of MMP‐9 in brain disorders appears to be its involvement in immune/inflammation responses that are related to the enzyme's ability to process and activate various cytokines and chemokines, as well as its contribution to blood–brain barrier disruption, facilitating the extravasation of leukocytes into brain parenchyma. However, another emerging possibility (i.e., the control of MMP‐9 over synaptic plasticity) should not be neglected. The translational potential of MMP‐9 has already been recognized in both the diagnosis and treatment domains. The most striking translational aspect may be the discovery of MMP‐9 up‐regulation in a mouse model of Fragile X syndrome, quickly followed by human studies and promising clinical trials that have sought to inhibit MMP‐9. With regard to diagnosis, suggestions have been made to use MMP‐9 alone or combined with tissue inhibitor of matrix metalloproteinase‐1 or brain‐derived neurotrophic factor as disease biomarkers. imageMMP‐9, through cleavage of specific target proteins, plays a major role in synaptic plasticity and neuroinflammation, and by those virtues contributes to brain physiology and a host of neurological and psychiatric disorders. This article is part of the60th Anniversary special issue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Matrix Metalloproteinase (MMP) 9 Transcription in Mouse Brain Induced by Fear Learning
Ganguly, K., Rejmak, E., Mikosz, M., Nikolaev, E., Knapska, E., & Kaczmarek, L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.457903 · Cited by 106
Self-citationRetractedRETRACTED AND REPLACED: Nerve growth factor metabolic dysfunction in Down’s syndrome brains
Iulita, M. F., Carmo, S. D., Ower, A. K., Fortress, A. M., Aguilar, L. F., Hanna, M., Wısnıewskı, T., Granholm, A., Buhusi, M. C., Busciglio, J. A., et al. (2014) · Brain · doi:10.1093/brain/awt372 · Cited by 96
RetractedLakka, S. S., Rajan, M., Gondi, C. S., Yanamandra, N., Chandrasekar, N., Jasti, S. L., Adachi, Y., Siddique, K., Gujrati, M., Olivero, W. C., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205894 · Cited by 92
RetractedDiagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Malenka, R. C., & Bear, M. F. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.012 · Cited by 3,968
Yatham, L., & Malhi, G. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199562305.001.0001 · Cited by 3,506
Structural basis of long-term potentiation in single dendritic spines
Matsuzaki, M., Honkura, N., Ellis-Davies, G. C. R., & Kasai, H. (2004) · Nature · doi:10.1038/nature02617 · Cited by 2,483
Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations
O’Roak, B. J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B. P., Levy, R., Ko, A., Lee, C., Smith, J. D., et al. (2012) · Nature · doi:10.1038/nature10989 · Cited by 2,165
The neuropathic pain triad: neurons, immune cells and glia
Scholz, J., & Woolf, C. J. (2007) · Nature Neuroscience · doi:10.1038/nn1992 · Cited by 1,732
Autism genome-wide copy number variation reveals ubiquitin and neuronal genes
Glessner, J. T., Wang, K., Cai, G., Korvatska, O., Kim, C. E., Wood, S., Zhang, H., Estes, A., Brune, C. W., Bradfield, J. P., et al. (2009) · Nature · doi:10.1038/nature07953 · Cited by 1,421
Dendritic spine changes associated with hippocampal long-term synaptic plasticity
Engert, F., & Bonhoeffer, T. (1999) · Nature · doi:10.1038/19978 · Cited by 1,412
The glutamate homeostasis hypothesis of addiction
Kalivas, P. W. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2515 · Cited by 1,350
Altered synaptic plasticity in a mouse model of fragile X mental retardation
Huber, K. M., Gallagher, S. M., Warren, S. T., & Bear, M. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122205699 · Cited by 1,349
Activation of microglial cells by β-amyloid protein and interferon-γ
Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314
Kawasaki, Y., Zhang, L., Cheng, J.-K., & Ji, R.-R. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3338-07.2008 · Cited by 1,162
In-vivo measurement of activated microglia in dementia
Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05625-2 · Cited by 1,054
Asahi, M., Wang, X., Mori, T., Sumii, T., Jung, J.-C., Moskowitz, M. A., Fini, M. E., & Lo, E. H. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07724.2001 · Cited by 1,004
Mandelkow, E. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01368-3 · Cited by 953
Matrix metalloproteinases in neuroinflammation
Rosenberg, G. A. (2002) · Glia · doi:10.1002/glia.10108 · Cited by 868
Burns, A., & Iliffe, S. (2009) · BMJ · doi:10.1136/bmj.b158 · Cited by 859
Vandooren, J., Van den Steen, P. E., & Opdenakker, G. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.770819 · Cited by 766
Kawasaki, Y., Xu, Z.-Z., Wang, X., Park, J. Y., Zhuang, Z.-Y., Tan, P.-H., Gao, Y.-J., Roy, K., Corfas, G., Lo, E. H., et al. (2008) · Nature Medicine · doi:10.1038/nm1723 · Cited by 757
Nociceptors Are Interleukin-1β Sensors
Binshtok, A. M., Wang, H., Zimmermann, K., Amaya, F., Vardeh, D., Shi, L., Brenner, G. J., Ji, R.-R., Bean, B. P., Woolf, C. J., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3795-08.2008 · Cited by 663
Matrix metalloproteinases and diseases of the CNS
Wee Yong, V., Forsyth, P. A., Bell, R., Krekoski, C. A., & Edwards, D. R. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01169-7 · Cited by 639
Regulation and function of adult neurogenesis: from genes to cognition.
Aimone, J. B., Li, Y., Lee, S. W., Clemenson, G. D., Deng, W., & Gage, F. H. (2014) · Physiological Reviews · doi:10.1152/physrev.00004.2014 · Cited by 635
Mechanisms of epileptogenesis and potential treatment targets
Pitkänen, A., & Lukasiuk, K. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70310-0 · Cited by 614
Asahi, M., Asahi, K., Jung, J.-C., del Zoppo, G. J., Fini, M. E., & Lo, E. H. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200012000-00007 · Cited by 610
Metalloproteinases: Mediators of Pathology and Regeneration in the CNS
Yong, V. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1807 · Cited by 582
Van Lint, P., & Libert, C. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0607338 · Cited by 564
Agrawal, S., Anderson, P., Durbeej, M., van Rooijen, N., Ivars, F., Opdenakker, G., & Sorokin, L. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051342 · Cited by 559
Metalloproteinases and their natural inhibitors in inflammation and immunity
Khokha, R., Murthy, A., & Weiss, A. (2013) · Nature reviews. Immunology · doi:10.1038/nri3499 · Cited by 552
Matrix metalloproteinases in immunity
Goetzl, E. J., Banda, M. J., & Leppert, D. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.1.1 · Cited by 544
Candelario-Jalil, E., Yang, Y., & Rosenberg, G. A. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.025 · Cited by 527
Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory
Nagy, V., Bozdagi, O., Matynia, A., Balcerzyk, M., Okulski, P., Dzwonek, J., Costa, R. M., Silva, A. J., Kaczmarek, L., & Huntley, G. W. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4359-05.2006 · Cited by 499
Self-citationThe role of inflammation in epileptogenesis
Vezzani, A., Friedman, A., & Dingledine, R. J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.04.004 · Cited by 495
(1973) · BMJ · doi:10.1136/bmj.2.5863.432 · Cited by 488
Jin, X., & Gereau, R. W. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3858-05.2006 · Cited by 486
Bilousova, T. V., Dansie, L., Ngo, M., Aye, J., Charles, J. R., Ethell, D. W., & Ethell, I. M. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.061796 · Cited by 465
Dendritic Spines: The Locus of Structural and Functional Plasticity
Sala, C., & Segal, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00012.2013 · Cited by 465
Farace, C., Melguizo, C., Asara, Y., Álvarez, P., Prados, J. C., Tolu, P., Delogu, G., Aránega, A., & Madeddu, R. (2011) · Cited by 464
Matrix metalloproteinase interactions with collagen and elastin
Van Doren, S. R. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.01.005 · Cited by 460
Increased Brain Expression of Matrix Metalloproteinase-9 After Ischemic and Hemorrhagic Human Stroke
Rosell, A., Ortega-Aznar, A., Alvarez-Sabín, J., Fernández-Cadenas, I., Ribó, M., Molina, C. A., Lo, E. H., & Montaner, J. (2006) · Stroke · doi:10.1161/01.str.0000223001.06264.af · Cited by 439
Leblond, C. S., Heinrich, J., Delorme, R., Proepper, C., Betancur, C., Huguet, G., Konyukh, M., Chaste, P., Ey, E., Rastam, M., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002521 · Cited by 429
Ohgaki, H. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-60327-492-0_14 · Cited by 418
Proteolytic Cascade Enzymes Increase in Focal Cerebral Ischemia in Rat
Rosenberg, G. A., Navratil, M., Barone, F., & Feuerstein, G. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199605000-00002 · Cited by 403
Szklarczyk, A., Lapinska, J., Rylski, M., McKay, R. D. G., & Kaczmarek, L. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00920.2002 · Cited by 392
Self-citationLevkovitz, Y., Mendlovich, S., Riwkes, S., Braw, Y., Levkovitch-Verbin, H., Gal, G., Fennig, S., Treves, I., & Kron, S. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04666yel · Cited by 387
Matrix Metalloproteinase-9 Degrades Amyloid-β Fibrils in Vitro and Compact Plaques in Situ
Yan, P., Hu, X., Song, H., Yin, K., Bateman, R. J., Cirrito, J. R., Xiao, Q., Hsu, F. F., Turk, J. W., Xu, J., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602440200 · Cited by 380 · cited 1×
“Moreover, Yan et al. (2006) reported that MMP-9 can degrade aggregated Ab fibrils and that the enzyme is induced by the presence of Ab, especially in reactive astrocytes that surround amyloid plaque.”
BackgroundMatrix metalloproteinases in brain development and remodeling: Synaptic functions and targets
Ethell, I. M., & Ethell, D. W. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21273 · Cited by 378
Wang, X., Jung, J., Asahi, M., Chwang, W., Russo, L., Moskowitz, M. A., Dixon, C. E., Fini, M. E., & Lo, E. H. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-18-07037.2000 · Cited by 371
Bar-Or, A. (2003) · Brain · doi:10.1093/brain/awg285 · Cited by 360
Domenici, E., Willé, D. R., Tozzi, F., Prokopenko, I., Miller, S., McKeown, A., Brittain, C., Rujescu, D., Giegling, I., Turck, C. W., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009166 · Cited by 347
Bruno, M. A., & Cuello, A. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510645103 · Cited by 344
Neural mechanisms of social risk for psychiatric disorders
Meyer-Lindenberg, A., & Tost, H. (2012) · Nature Neuroscience · doi:10.1038/nn.3083 · Cited by 340
Backstrom, J. R., Lim, G. P., Cullen, M. J., & Tökés, Z. A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-24-07910.1996 · Cited by 331 · cited 2×
“Backstrom et al. (1996) studied postmortem brain tissue from AD patients and reported that MMP-9 was localized to neurons in the hippocampus and capable of degrading Ab.”
BackgroundClark, A. W., Krekoski, C. A., Bou, S.-S., Chapman, K. R., & Edwards, D. R. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00859-8 · Cited by 328
Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics
Bagni, C., Tassone, F., Neri, G., & Hagerman, R. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63141 · Cited by 321 · cited 1×
“The list of other frequent FXS symptoms includes developmental delays, anxiety, compulsive behavior, attention-deficit/hyperactivity disorder, and epilepsy (Huber et al. 2002; Bagni et al. 2012; Berry-Kravis 2014; Hagerman and Polussa 2015).”
BackgroundWang, L., Zhang, Z. G., Zhang, R. L., Gregg, S. R., Hozeska-Solgot, A., LeTourneau, Y., Wang, Y., & Chopp, M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5380-05.2006 · Cited by 316
Wang, X.-B., Bozdagi, O., Nikitczuk, J. S., Zhai, Z. W., Zhou, Q., & Huntley, G. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807248105 · Cited by 316
Neuronal Matrix Metalloproteinase-9 Is a Determinant of Selective Neurodegeneration
Kaplan, A., Spiller, K. J., Towne, C., Kanning, K. C., Choe, G. T., Geber, A., Akay, T., Aebischer, P., & Henderson, C. E. (2014) · Neuron · doi:10.1016/j.neuron.2013.12.009 · Cited by 306
Cauwe, B., & Opdenakker, G. (2010) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2010.501783 · Cited by 299
Leigh, M. J. S., Nguyen, D. V., Mu, Y., Winarni, T. I., Schneider, A., Chechi, T., Polussa, J., Doucet, P., Tassone, F., Rivera, S. M., et al. (2013) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e318287cd17 · Cited by 298
MMP-9 Inhibition: a Therapeutic Strategy in Ischemic Stroke
Chaturvedi, M., & Kaczmarek, L. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8538-z · Cited by 296
Self-citationImportant role of matrix metalloproteinase 9 in epileptogenesis
Wilczynski, G. M., Konopacki, F. A., Wilczek, E., Lasiecka, Z., Gorlewicz, A., Michaluk, P., Wawrzyniak, M., Malinowska, M., Okulski, P., Kolodziej, L. R., et al. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200708213 · Cited by 292
Self-citationLee, S.-R., Kim, H.-Y., Rogowska, J., Zhao, B.-Q., Bhide, P., Parent, J. M., & Lo, E. H. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4085-05.2006 · Cited by 286
Meighan, S. E., Meighan, P. C., Choudhury, P., Davis, C. J., Olson, M. L., Zornes, P. A., Wright, J. W., & Harding, J. W. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03565.x · Cited by 285
Higashida, T., Kreipke, C. W., Rafols, J. A., Peng, C., Schafer, S., Schafer, P., Ding, J. Y., Dornbos, D., Li, X., Guthikonda, M., et al. (2011) · Journal of Neurosurgery · doi:10.3171/2010.6.jns10207 · Cited by 282
Yoshida, T., Ishikawa, M., Niitsu, T., Nakazato, M., Watanabe, H., Shiraishi, T., Shiina, A., Hashimoto, T., Kanahara, N., Hasegawa, T., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042676 · Cited by 277
Synaptic circuit remodelling by matrix metalloproteinases in health and disease
Huntley, G. W. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3320 · Cited by 267
Past and Present Definitions of Epileptogenesis and Its Biomarkers
Pitkänen, A., & Engel, J. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0257-2 · Cited by 264
Dubois, B., Masure, S., Hurtenbach, U., Paemen, L., Heremans, H., van den Oord, J., Sciot, R., Meinhardt, T., Hämmerling, G., Opdenakker, G., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6886 · Cited by 262
Leppert, D., Leib, S. L., Grygar, C., Miller, K. M., Schaad, U. B., & Holländer, G. A. (2000) · Clinical Infectious Diseases · doi:10.1086/313922 · Cited by 259
Bergmann, O., Spalding, K. L., & Frisén, J. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a018994 · Cited by 256
Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain
Dzwonek, J., Rylski, M., & Kaczmarek, L. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.03.070 · Cited by 256
Self-citationElevated levels of M(r) 92,000 type IV collagenase in human brain tumors.
Rao, J. S., Steck, P. A., Mohanam, S., Stetler‐Stevenson, W. G., Liotta, L. A., & Sawaya, R. A. (1993) · PubMed · Cited by 255
Leppert, D., Lindberg, R. L. P., Kappos, L., & Leib, S. L. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00101-1 · Cited by 255
Jin, R., Yang, G., & Li, G. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.03.008 · Cited by 252
Textbook of Traumatic Brain Injury
OʼDell, M. W. (2006) · Journal of Head Trauma Rehabilitation · doi:10.1097/00001199-200601000-00011 · Cited by 250
Matrix metalloproteinases as therapeutic targets for stroke
Yang, Y., & Rosenberg, G. A. (2015) · Brain Research · doi:10.1016/j.brainres.2015.04.024 · Cited by 246
Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer’s disease.
Lorenzl, S. (2003) · Neurochemistry International · doi:10.1016/s0197-0186(03)00004-4 · Cited by 243
Anderson, I. M., Haddad, P. M., & Scott, J. (2012) · BMJ · doi:10.1136/bmj.e8508 · Cited by 238
Svedin, P., Hagberg, H., Sävman, K., Zhu, C., & Mallard, C. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4391-06.2007 · Cited by 236
Transsynaptic Signaling by Activity-Dependent Cleavage of Neuroligin-1
Peixoto, R. T., Kunz, P. A., Kwon, H., Mabb, A. M., Sabatini, B. L., Philpot, B. D., & Ehlers, M. D. (2012) · Neuron · doi:10.1016/j.neuron.2012.07.006 · Cited by 227
Butler, G. S., & Overall, C. M. (2009) · Biochemistry · doi:10.1021/bi901656f · Cited by 224
Extension of the Thrombolytic Time Window With Minocycline in Experimental Stroke
Murata, Y., Rosell, A., Scannevin, R. H., Rhodes, K. J., Wang, X., & Lo, E. H. (2008) · Stroke · doi:10.1161/strokeaha.108.514026 · Cited by 224
Open-label add-on treatment trial of minocycline in fragile X syndrome.
Paribello, C., Tao, L., Folino, A., Berry-Kravis, E., Tranfaglia, M., Ethell, I. M., & Ethell, D. W. (2010) · BMC Neurology · doi:10.1186/1471-2377-10-91 · Cited by 223
Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?
Rivera, S., Khrestchatisky, M., Kaczmarek, L., Rosenberg, G. A., & Jaworski, D. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3467-10.2010 · Cited by 223
Self-citationMatrix Metalloproteinase-9 as a Marker for Acute Ischemic Stroke: A Systematic Review
Ramos-Fernandez, M., Bellolio, M. F., & Stead, L. G. (2011) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2009.10.008 · Cited by 220
Song, J., Wu, C., Korpos, E., Zhang, X., Agrawal, S. M., Wang, Y., Faber, C., Schäfers, M., Körner, H., Opdenakker, G., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.01.037 · Cited by 220
Reinhard, S. M., Razak, K., & Ethell, I. M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00280 · Cited by 219
The expression of matrix metalloproteinase-2 and-9 in human gliomas of different pathological grades
Wang, M., Wang, T., Liu, S., Yoshida, D., & Teramoto, A. (2003) · Brain Tumor Pathology · doi:10.1007/bf02483449 · Cited by 219
Influence of matrix metalloproteinase MMP-9 on dendritic spine morphology
Michaluk, P., Wawrzyniak, M., Alot, P., Szczot, M., Wyrembek, P., Mercik, K., Medvedev, N., Wilczek, E., De Roo, M., Zuschratter, W., et al. (2011) · Journal of Cell Science · doi:10.1242/jcs.090852 · Cited by 214
Self-citationThe trouble with spines in fragile X syndrome: density, maturity and plasticity
He, C. X., & Portera-Cailliau, C. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.03.049 · Cited by 214
Matrix Metalloproteinase-9 Controls NMDA Receptor Surface Diffusion through Integrin β1 Signaling
Michaluk, P., Mikasova, L., Groc, L., Frischknecht, R., Choquet, D., & Kaczmarek, L. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5346-08.2009 · Cited by 206
Self-citationDistinct neuroinflammatory profile in post-mortem human Huntington's disease
Silvestroni, A., Faull, R. L. M., Strand, A. D., & Möller, T. (2009) · NeuroReport · doi:10.1097/wnr.0b013e32832e34ee · Cited by 203
Gkogkas, C. G., Khoutorsky, A., Cao, R., Jafarnejad, S. M., Prager-Khoutorsky, M., Giannakas, N., Kaminari, A., Fragkouli, A., Nader, K., Price, T. J., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.064 · Cited by 201
The role of matrix metalloproteinases in glioma invasion
Nakada, M. (2003) · Frontiers in Bioscience · doi:10.2741/1016 · Cited by 201
Barkho, B. Z., Munoz, A. E., Li, X., Li, L., Cunningham, L. A., & Zhao, X. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0519 · Cited by 201
Mizoguchi, H., Nakade, J., Tachibana, M., Ibi, D., Someya, E., Koike, H., Kamei, H., Nabeshima, T., Itohara, S., Takuma, K., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3118-11.2011 · Cited by 199
The role of BDNF in the pathophysiology and treatment of schizophrenia
Favalli, G., Li, J., Belmonte-de-Abreu, P., Wong, A. H. C., & Daskalakis, Z. J. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.09.022 · Cited by 196
Verslegers, M., Lemmens, K., Van Hove, I., & Moons, L. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.03.004 · Cited by 195
Metalloproteinases: A parade of functions in matrix biology and an outlook for the future
Apte, S. S., & Parks, W. C. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.04.005 · Cited by 193
Pathological circuit function underlying addiction and anxiety disorders
Lüthi, A., & Lüscher, C. (2014) · Nature Neuroscience · doi:10.1038/nn.3849 · Cited by 192
β-Dystroglycan as a Target for MMP-9, in Response to Enhanced Neuronal Activity
Michaluk, P., Kolodziej, L., Mioduszewska, B., Wilczynski, G. M., Dzwonek, J., Jaworski, J., Gorecki, D. C., Ottersen, O. P., & Kaczmarek, L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700641200 · Cited by 189
Self-citationVaillant, C., Didier-Bazès, M., Hutter, A., Belin, M.-F., & Thomasset, N. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-04994.1999 · Cited by 188
Miller, J. P., Holcomb, J., Al-Ramahi, I., de Haro, M., Gafni, J., Zhang, N., Kim, E., Sanhueza, M., Torcassi, C., Kwak, S., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.06.021 · Cited by 186
Matrix Metalloproteinase 9 Facilitates West Nile Virus Entry into the Brain
Wang, P., Dai, J., Bai, F., Kong, K.-F., Wong, S. J., Montgomery, R. R., Madri, J. A., & Fikrig, E. (2008) · Journal of Virology · doi:10.1128/jvi.00314-08 · Cited by 186
Roe, K., Kumar, M., Lum, S., Orillo, B., Nerurkar, V. R., & Verma, S. (2012) · Journal of General Virology · doi:10.1099/vir.0.040899-0 · Cited by 185
The critical role of cyclin D2 in adult neurogenesis
Kowalczyk, A., Filipkowski, R. K., Rylski, M., Wilczynski, G. M., Konopacki, F. A., Jaworski, J., Ciemerych, M. A., Sicinski, P., & Kaczmarek, L. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200404181 · Cited by 184
Self-citationInflammation in schizophrenia: A question of balance
Leza, J. C., García-Bueno, B., Bioque, M., Arango, C., Parellada, M., Do, K., O’Donnell, P., & Bernardo, M. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.014 · Cited by 182
Bozdagi, O., Nagy, V., Kwei, K. T., & Huntley, G. W. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00202.2007 · Cited by 182
Bjerke, M., Zetterberg, H., Edman, Å., Blennow, K., Wallin, A., & Andreasson, U. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110566 · Cited by 180
CD44: molecular interactions, signaling and functions in the nervous system
Dzwonek, J., & Wilczynski, G. M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00175 · Cited by 179
Jourquin, J., Tremblay, E., Décanis, N., Charton, G., Hanessian, S., Chollet, A., Le Diguardher, T., Khrestchatisky, M., & Rivera, S. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02876.x · Cited by 178
Amyloid-Degrading Enzymes as Therapeutic Targets in Alzheimers Disease
Nalivaeva, N., Fisk, L., Belyaev, N., & Turner, A. (2008) · Current Alzheimer Research · doi:10.2174/156720508783954785 · Cited by 177
Tian, L., Stefanidakis, M., Ning, L., Van Lint, P., Nyman-Huttunen, H., Libert, C., Itohara, S., Mishina, M., Rauvala, H., & Gahmberg, C. G. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200612097 · Cited by 173
Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas
Rao, J. S., Yamamoto, M., Mohaman, S., Gokaslan, Z. L., Fuller, G. N., Stetler-Stevenson, W. G., Rao, V. H., Liotta, L. A., Nicolson, G. L., & Sawaya, R. E. (1996) · Clinical & Experimental Metastasis · doi:10.1007/bf00157681 · Cited by 169
Matrix metalloprotease regulation of neuropathic pain
Ji, R.-R., Xu, Z.-Z., Wang, X., & Lo, E. H. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.04.002 · Cited by 168
Redondo-Muñóz, J., Ugarte-Berzal, E., Terol, M. J., den Steen, P. E. V., del Cerro, M. H., Roderfeld, M., Roeb, E., Opdenakker, G., Garcia-Marco, J. A., & Garcı́a-Pardo, A. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.044 · Cited by 167
Mantuano, E., Inoue, G., Li, X., Takahashi, K., Gaultier, A., Gonias, S. L., & Campana, W. M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3053-08.2008 · Cited by 167
Lindberg, R. L. P. (2001) · Brain · doi:10.1093/brain/124.9.1743 · Cited by 166
Zhang, H., Chang, M., Hansen, C. N., Basso, D. M., & Noble-Haeusslein, L. J. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0038-0 · Cited by 163
Deb, S., & Gottschall, P. E. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66041641.x · Cited by 163
Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis
Kieseier, B. (1998) · Brain · doi:10.1093/brain/121.1.159 · Cited by 163
Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators
Yong, V. W., Zabad, R., Agrawal, S., DaSilva, A. G., & Metz, L. M. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.11.021 · Cited by 162
High MMP-9 activity levels in fragile X syndrome are lowered by minocycline
Dziembowska, M., Pretto, D. I., Janusz, A., Kaczmarek, L., Leigh, M. J., Gabriel, N., Durbin‐Johnson, B., Hagerman, R. J., & Tassone, F. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36023 · Cited by 161
Self-citationNeuroimmune Mechanisms of Alcohol and Drug Addiction
Cui, C., Shurtleff, D., & Harris, R. A. (2014) · International Review of Neurobiology · doi:10.1016/b978-0-12-801284-0.00001-4 · Cited by 161
Kondraganti, S. R., Mohanam, S., Chintala, S. K., Kin, Y., Jasti, S. L., Nirmala, C., Lakka, S. S., Adachi, Y., Kyritsis, A. P., Ali‐Osman, F., et al. (2000) · PubMed · Cited by 160
TIMP-1 Abolishes MMP-9-Dependent Long-lasting Long-term Potentiation in the Prefrontal Cortex
Okulski, P., Jay, T. M., Jaworski, J., Duniec, K., Dzwonek, J., Konopacki, F. A., Wilczynski, G. M., Sánchez‐Capelo, A., Mallet, J. J., & Kaczmarek, L. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.012 · Cited by 159
Self-citationBiobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma
Lutgendorf, S. K., Lamkin, D. M., Jennings, N. B., Arevalo, J. M. G., Penedo, F., DeGeest, K., Langley, R. R., Lucci, J. A., Cole, S. W., Lubaroff, D. M., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0230 · Cited by 158 · cited 1×
“Lutgendorf et al. (2008) reported elevations of MMP-9 in CD68 + cells in depressed patients with ovarian cancer compared with those who were not depressed.”
BackgroundShigemori, Y., Katayama, Y., Mori, T., Maeda, T., & Kawamata, T. (2006) · Acta Neurochirurgica Supplementum · doi:10.1007/3-211-30714-1_29 · Cited by 158
Kaczmarek, L., Dzwonek, J., & Szymczak, S. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf676 · Cited by 157
Self-citationSidhu, H., Dansie, L. E., Hickmott, P. W., Ethell, D. W., & Ethell, I. M. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1162-14.2014 · Cited by 155 · cited 2×
“Under normal conditions, this occurs between PND14 and PND21 (Sidhu et al. 2014).”
BackgroundGrossetete, M., Phelps, J., Arko, L., Yonas, H., & Rosenberg, G. A. (2009) · Neurosurgery · doi:10.1227/01.neu.0000351768.11363.48 · Cited by 153
Plasma inflammatory biomarkers for Huntington’s disease patients and mouse model
Chang, K., Wu, Y., Chen, Y., & Chen, C. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.09.011 · Cited by 153
Lorenzl, S., Albers, D. S., Narr, S., Chirichigno, J. W., & Beal, M. F. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.8019 · Cited by 152
The Neuroendocrine Impact of Chronic Stress on Cancer
Thaker, P. H., Lutgendorf, S. K., & Sood, A. K. (2007) · Cell Cycle · doi:10.4161/cc.6.4.3829 · Cited by 152
Verma, S., Kumar, M., Gurjav, U., Lum, S., & Nerurkar, V. R. (2010) · Virology · doi:10.1016/j.virol.2009.10.036 · Cited by 151
Reijerkerk, A., Kooij, G., van der Pol, S. M. A., Khazen, S., Dijkstra, C. D., & de Vries, H. E. (2006) · The FASEB Journal · doi:10.1096/fj.06-6099fje · Cited by 146
Larsen, P. H., DaSilva, A. G., Conant, K. E., & Yong, V. W. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1880-05.2006 · Cited by 145
Nerve growth factor metabolic dysfunction in Alzheimer's disease and Down syndrome
Iulita, M. F., & Cuello, A. C. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.04.010 · Cited by 144
MMP-9 deficiency affects axonal outgrowth, migration, and apoptosis in the developing cerebellum
Vaillant, C. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00196-9 · Cited by 141
van der Kooij, M. A., Fantin, M., Rejmak, E., Grosse, J., Zanoletti, O., Fournier, C., Ganguly, K., Kalita, K., Kaczmarek, L., & Sandi, C. (2014) · Nature Communications · doi:10.1038/ncomms5995 · Cited by 140
Self-citationAdair, J. C., Charlie, J., Dencoff, J. E., Kaye, J. A., Quinn, J. F., Camicioli, R. M., Stetler‐Stevenson, W. G., & Rosenberg, G. A. (2004) · Stroke · doi:10.1161/01.str.0000127420.10990.76 · Cited by 140
Liu, F., Guo, X., Wu, R., Ou, J., Zheng, Y., Zhang, B., Xie, L., Zhang, L., Yang, L., Yang, S., et al. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.01.011 · Cited by 137
Kiaei, M., KIPIANI, K., Calingasan, N. Y., Wille, E. J., CHEN, J., Heissig, B., Rafii, S., Lorenzl, S., & Beal, M. F. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.01.036 · Cited by 137
Adult Neurogenesis and the Future of the Rejuvenating Brain Circuits
Lepousez, G., Nissant, A., & Lledo, P. (2015) · Neuron · doi:10.1016/j.neuron.2015.01.002 · Cited by 136
Proteases and Glioma Angiogenesis
Lakka, S. S., Gondi, C. S., & Rao, J. S. (2005) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00118.x · Cited by 136
Matrix Metalloproteinases and Neuroinflammation in Multiple Sclerosis
Rosenberg, G. A. (2002) · The Neuroscientist · doi:10.1177/1073858402238517 · Cited by 135
Synaptic plasticity mediating cocaine relapse requires matrix metalloproteinases
Smith, A. C. W., Kupchik, Y. M., Scofield, M. D., Gipson, C. D., Wiggins, A., Thomas, C. A., & Kalivas, P. W. (2014) · Nature Neuroscience · doi:10.1038/nn.3846 · Cited by 135
Rivera, S., Tremblay, E., Timsit, S., Canals, O., Ben-Ari, Y., & Khrestchatisky, M. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-11-04223.1997 · Cited by 135
MMP9: A novel function in synaptic plasticity
Dziembowska, M., & Włodarczyk, J. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.01.023 · Cited by 134
Activity-Dependent Local Translation of Matrix Metalloproteinase-9
Dziembowska, M., Miłek, J., Janusz, A., Rejmak, E., Romanowska, E., Górkiewicz, T., Tiron, A., Bramham, C. R., & Kaczmarek, L. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6028-11.2012 · Cited by 133
Self-citationRotschafer, S. E., Trujillo, M. S., Dansie, L. E., Ethell, I. M., & Razak, K. A. (2012) · Brain Research · doi:10.1016/j.brainres.2011.12.041 · Cited by 130
Asahina, M., Yoshiyama, Y., & Hattori, T. (2001) · PubMed · Cited by 129
Methamphetamine effects on blood-brain barrier structure and function
Northrop, N. A., & Yamamoto, B. K. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00069 · Cited by 125
Jaholkowski, P. P., Kiryk, A., Jedynak, P., Abdallah, N. M. ‐. B., Knapska, E., Kowalczyk, A. E., Piechal, A., Blecharz‐Klin, K., Figiel, I., Lioudyno, V. I., et al. (2009) · Learning & Memory · doi:10.1101/lm.1459709 · Cited by 125
Self-citationGalboiz, Y., Shapiro, S., Lahat, N., Rawashdeh, H., & Miller, A. (2001) · Annals of Neurology · doi:10.1002/ana.1218 · Cited by 125
Brown, T. E., Forquer, M. R., Cocking, D. L., Jansen, H. T., Harding, J. W., & Sorg, B. A. (2007) · Learning & Memory · doi:10.1101/lm.476207 · Cited by 121
Matrix metalloproteinases as drug targets in ischemia/reperfusion injury
Dejonckheere, E., Vandenbroucke, R. E., & Libert, C. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.06.009 · Cited by 120
Mash, D. C., ffrench‐Mullen, J. M. H., Adi, N., Qin, Y., Buck, A., & Pablo, J. P. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001187 · Cited by 120
Hu, F., Ku, M., Markovic, D. S., Dzaye, O. D. A., Lehnardt, S., Synowitz, M., Wolf, S. A., & Kettenmann, H. (2014) · International Journal of Cancer · doi:10.1002/ijc.28908 · Cited by 119
Conant, K. E., Wang, Y., Szklarczyk, A., Dudak, A., Mattson, M. P., & Lim, S. T. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2009.12.061 · Cited by 118
Hooper, N. M. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330335 · Cited by 117
Gondi, C. S., Lakka, S. S., Dinh, D. H., Olivero, W. C., Gujrati, M., & Rao, J. S. (2004) · Neuron Glia Biology · doi:10.1017/s1740925x04000237 · Cited by 115
The Fragile X mental retardation protein regulates matrix metalloproteinase 9 mRNA at synapses.
Janusz, A., Miłek, J., Perycz, M., Pacini, L., Bagni, C., Kaczmarek, L., & Dziembowska, M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2207-13.2013 · Cited by 112
Self-citationZhang, J. W., Deb, S., & Gottschall, P. E. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00347.x · Cited by 111
Nagy, V., Bozdagi, O., & Huntley, G. W. (2007) · Learning & Memory · doi:10.1101/lm.678307 · Cited by 107
Gimsa, U., Mitchison, N. A., & Brunner-Weinzierl, M. C. (2013) · Mediators of Inflammation · doi:10.1155/2013/320519 · Cited by 107
Reeves, T. M., Prins, M. L., Zhu, J., Povlishock, J. T., & Phillips, L. L. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-32-10182.2003 · Cited by 105
Yamamori, H., Hashimoto, R., Ishima, T., Kishi, F., Yasuda, Y., Ohi, K., Fujimoto, M., Umeda-Yano, S., Ito, A., Hashimoto, K., et al. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.09.059 · Cited by 101 · cited 3×
“over, the plasma levels of MMP-9 and its endogenous inhibitor TIMP-1 were shown to be elevated in schizophrenia patients (Domenici et al. 2010; Chang et al. 2011; Yamamori et al. 2013).”
BackgroundGawlak, M., Górkiewicz, T., Gorlewicz, A., Konopacki, F. A., Kaczmarek, L., & Wilczynski, G. M. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.05.045 · Cited by 101
Self-citationAdult Hippocampal Neurogenesis in Natural Populations of MammalsPreprint
Amrein, I. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021295 · Cited by 101
Leppert, D., Hughes, P., Huber, S., Erne, B., Grygar, C., Saïd, G., Miller, K., Steck, A. J., Probst, A., & Fuhr, P. (1999) · Neurology · doi:10.1212/wnl.53.1.62 · Cited by 99
Immune privilege of the CNS is not the consequence of limited antigen sampling
Harris, M. G., Hulseberg, P. D., Ling, C., Kármán, J., Clarkson, B. D. S., Harding, J. S., Zhang, M., Sandor, A., Christensen, K., Nagy, A., et al. (2014) · Scientific Reports · doi:10.1038/srep04422 · Cited by 96
RYBAKOWSKI, J. K., Remlinger-Molenda, A., Czech-Kucharska, A., Wójcicka, M., Michalak, M., & Losy, J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.07.019 · Cited by 91
Reward Learning Requires Activity of Matrix Metalloproteinase-9 in the Central Amygdala
Knapska, E., Lioudyno, V. I., Kiryk, A., Mikosz, M., Górkiewicz, T., Michaluk, P., Gawlak, M., Chaturvedi, M., Mochol, G., Balcerzyk, M., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5239-12.2013 · Cited by 91
Self-citationMizoguchi, H., Takuma, K., Fukuzaki, E., Ibi, D., Someya, E., Akazawa, K.-H., Alkam, T., Tsunekawa, H., Mouri, A., Noda, Y., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.154724 · Cited by 91
Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice
Fragkouli, A., Tsilibary, E. C., & Tzinia, A. K. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.06.021 · Cited by 90
The neurobiology of social environmental risk for schizophrenia: an evolving research field
Akdeniz, C., Tost, H., & Meyer‐Lindenberg, A. (2014) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-014-0858-4 · Cited by 90
Mechanism-Based Treatments in Neurodevelopmental Disorders: Fragile X Syndrome
Berry‐Kravis, E. (2013) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2013.12.001 · Cited by 88
Ingraham, C. A., Park, G. C., Makarenkova, H. P., & Crossin, K. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.229427 · Cited by 88
Matrix metalloproteinase-9 involvement in the structural plasticity of dendritic spines
Stawarski, M., Stefaniuk, M., & Włodarczyk, J. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00068 · Cited by 88
Pathogenesis of neuropsychiatric systemic lupus erythematosus and potential biomarkers
Efthimiou, P., & Blanco, M. (2009) · Modern Rheumatology · doi:10.1007/s10165-009-0198-5 · Cited by 88
Li, Y.-J., Wang, Z.-H., Zhang, B., Xiao, Z., Wang, M.-J., Shi, S., Bai, J., Lin, T., Guo, C., Zhang, S.-J., et al. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-80 · Cited by 87
Ethanol-induced impairment of spatial memory and brain matrix metalloproteinases
Wright, J. W., Masino, A. J., Reichert, J. R., Turner, G. D., Meighan, S. E., Meighan, P. C., & Harding, J. W. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04036-2 · Cited by 86
Södersten, K., Pålsson, E., Ishima, T., Funa, K., Landén, M., Hashimoto, K., & Ågren, H. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.01.009 · Cited by 86
Hayashi, T., Kaneko, Y., Yu, S., Bae, E. C., Stahl, C. E., Kawase, T., van Loveren, H., Sanberg, P. R., & Borlongan, C. V. (2009) · Brain Research · doi:10.1016/j.brainres.2009.05.040 · Cited by 85
Szepesi, Z., Hosy, E., Ruszczycki, B., Bijata, M., Pyskaty, M., Bikbaev, A., Heine, M., Choquet, D., Kaczmarek, L., & Wlodarczyk, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098274 · Cited by 83
Self-citationMultiple sclerosis- diagnosis, management and prognosis.
Tsang, B. K.-T., & Macdonell, R. (2011) · PubMed · Cited by 83
Kuzniewska, B., Rejmak, E., Malik, A. R., Jaworski, J., Kaczmarek, L., & Kalita, K. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00008-13 · Cited by 82
Self-citationGelatinases (MMP-2 and MMP-9) are preferentially expressed by Th1 vs. Th2 cells
Abraham, M., Shapiro, S., Karni, A., Weiner, H. L., & Miller, A. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.02.001 · Cited by 79
Annese, V., Herrero, M. T., Pentima, M. D., Gómez, A., Lombardi, L., Ros, C. M. B., de Pablos, V., Fernández‐Villalba, E., & Stefano, M. E. D. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0718-8 · Cited by 78
Neural ECM proteases in learning and synaptic plasticity
Tsilibary, E. C., Tzinia, A. K., Radenović, L., Stamenković, V., Lebitko, T., Mucha, M. W., Pawlak, R., Frischknecht, R., & Kaczmarek, L. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63486-3.00006-2 · Cited by 77
Self-citationMandler, R. N., Dencoff, J. D., Midani, F., Ford, C. C., Ahmed, W., & Rosenberg, G. A. (2001) · Brain · doi:10.1093/brain/124.3.493 · Cited by 77
Matrix Metalloproteinase-9 as a Novel Player in Synaptic Plasticity and Schizophrenia: Table 1.
Łepeta, K., & Kaczmarek, L. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv036 · Cited by 77
Self-citationMizoguchi, H., Yamada, K., Niwa, M., Mouri, A., Mizuno, T., Noda, Y., Nitta, A., Itohara, S., Banno, Y., & Nabeshima, T. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04288.x · Cited by 76
Functional polymorphism of the matrix metalloproteinase-9 (MMP-9) gene in schizophrenia.
Rybakowski, J. K., Skibinska, M., Kapelski, P., Kaczmarek, L., & Hauser, J. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.02.005 · Cited by 76
Self-citationUnderstanding epileptogenesis in calcified neurocysticercosis with perfusion MRI
Gupta, R. K., Awasthi, R., Rathore, R. K. S., Verma, A., Sahoo, P., Paliwal, V. K., Prasad, K. N., Pandey, C. M., & Narayana, P. A. (2012) · Neurology · doi:10.1212/wnl.0b013e318248deae · Cited by 74
Amniotic Fluid MMP ‐9 and Neurotrophins in Autism Spectrum Disorders: An Exploratory Study
Abdallah, M. W., Pearce, B. D., Larsen, N., Greaves‐Lord, K., Nørgaard‐Pedersen, B., HOUGAARD, D. M., Mortensen, E. L., & Grove, J. (2012) · Autism Research · doi:10.1002/aur.1254 · Cited by 73
Research works printed but not linked: 12
- 10.3109/s10165-009-0198-5 · doi:10.3109/s10165-009-0198-5
- Goldenberg M. M., 2012, Multiple sclerosis review, P. T., 37, 175
- 10.1371/journal.pone.0028499 · doi:10.1371/journal.pone.0028499
- 10.1007/s00296-003-0380-6 · doi:10.1007/s00296-003-0380-6
- 10.2174/138920108783497631 · doi:10.2174/138920108783497631
- 10.1016/j.neuron.2012.10.025 · doi:10.1016/j.neuron.2012.10.025
- Scalea T. M., 2005, Neurotrauma: Evidence‐Based Answers To Common Questions, 3
- 10.1007/s12264-012-1296-5 · doi:10.1007/s12264-012-1296-5
- Szklarczyk A., 2005, Physiology of matrix MMPs and their tissue inhibitors in the brain, Biotech. Int., 17, 15
- 10.1089/neu.2009.0959 · doi:10.1089/neu.2009.0959
- 10.1007/s12035-014-8850-2 · doi:10.1007/s12035-014-8850-2
- Zhao W. J., 2012, Differential expression of MMP‐9 and AQP4 in human glioma samples, Folia Neuropathol., 50, 176
Cited by
BDNF: A Key Factor with Multipotent Impact on Brain Signaling and Synaptic Plasticity
Kowiański, P., Lietzau, G., Czuba, E., Waśkow, M., Steliga, A., & Moryś, J. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-017-0510-4 · Cited by 1,359
Colucci-D’Amato, L., Speranza, L., & Volpicelli, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207777 · Cited by 991
Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease
Moussa, C., Hebron, M., Huang, X., Ahn, J., Rissman, R. A., Aisen, P. S., & Turner, R. S. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0779-0 · Cited by 705
Brain-Derived Neurotrophic Factor in Alzheimer’s Disease and Its Pharmaceutical Potential
Gao, L., Zhang, Y., Sterling, K., & Song, W. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00279-0 · Cited by 606
Scofield, M. D., Heinsbroek, J. A., Gipson, C. D., Kupchik, Y. M., Spencer, S., Smith, A. C. W., Roberts-Wolfe, D., & Kalivas, P. W. (2016) · Pharmacological Reviews · doi:10.1124/pr.116.012484 · Cited by 598
Metadata
- Authors
- Vafadari, B., Salamian, A., & Kaczmarek, L.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2016-03-21
- Volume
- 139
- Issue
- S2
- Pages
- 91-114
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1961885071
- Cited by
- 382
- References
- 300
- FWCI
- 7.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- Funders
- EXTRABRAIN 7th Framework Marie Curie European Union Initial Training Network
- Polish Ministry of Science and Higher Education
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.